Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 22 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT04360941
- Conditions
- Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +10 more
- Locations
-
- The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
- Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
- Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
- Hope Clinical Trials Cancer Centre Leicester, United Kingdom
NCT04824014
- Conditions
- ER+ Breast Cancer
- Locations
-
- Université deSherbrooke Sherbrooke, Quebec, Canada
NCT05534438
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
Recruiting
Circulating Tumor DNA
NCT06923527
- Conditions
- ER+ Breast Cancer
- Locations
-
- Yale University New Haven, Connecticut, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
NCT07483307
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +14 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT06681064
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Royal Marsden NHS Foundation Trust London, United Kingdom
NCT06395519
- Conditions
- Adnexal Diseases, Advanced or Metastatic Solid Tumors, BRCA Mutation, +52 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Yale University, Yale Cancer Center New Haven, Connecticut, United States
- Mayo Clinic Jacksonville, Florida, United States
- University of Chicago Medical Center Chicago, Illinois, United States
NCT05490472
- Conditions
- ARID1A Gene Mutation, Breast Diseases, Breast Neoplasms, +17 more
- Locations
-
- Henry Ford Health System Detroit, Michigan, United States
- Washington University St Louis, Missouri, United States
- Mary Crowley Cancer Research Dallas, Texas, United States
- University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States
NCT07002177
- Conditions
- Breast Cancer Stage I, Breast Cancer Stage II, Breast Diseases, +8 more
- Locations
-
- Fudan University Shanghai Cancer Center, Shanghai Shanghai, China
NCT06867484
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Lynn Cancer Institute at Baptist Health, Inc. Boca Raton, Florida, United States
- Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
- Conditions
- ER+ Breast Cancer, HER2-negative Breast Cancer
- Locations
-
- Institut de Cancérologie de l'Ouest Angers, France
- Centre Hospitalier Annecy Genevois_Site d'Annecy Annecy, France
- Institut du Cancer Avignon Sainte Catherine Avignon, France
- Centre Hospitalier Simone Veil de Blois Blois, France
Not Yet Recruiting
Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.
NCT07443774
- Conditions
- Abemaciclib, Breast Cancer, Breast Diseases, +9 more
- Locations
-
- CHU Grenoble Alpes Grenoble, France
Not Yet Recruiting
Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer
NCT06407401
- Conditions
- Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, +17 more
- Locations
-
Not specified
Completed
Alcohol and Breast Cancer (ABC) Trial
NCT05423730
- Conditions
- Aromatase Inhibitors, Breast Cancer, Breast Diseases, +6 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT00828854
- Conditions
- Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +4 more
- Locations
-
- St. Vincent's University Hospital Dublin, Ireland
- The University of Birmingham Birmingham, United Kingdom
- Velindre Hospital - Whitchurch Cardiff, United Kingdom
- Whiston Hospital; Clatterbridge Centre for Oncology Liverpool, United Kingdom
NCT00676663
- Conditions
- Animal Diseases, Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, +9 more
- Locations
-
- California Cancer Care Greenbrae, California, United States
- Moores UCSD Cancer Center La Jolla, California, United States
- Scripps Health La Jolla, California, United States
- University of Colorado Aurora, Colorado, United States
NCT04312347
- Conditions
- Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +4 more
- Locations
-
- MRCCC Siloam Hospital Semanggi Jakarta, DKI Jakarta, Indonesia
NCT02580448
- Conditions
- Advanced Breast Cancer, Breast Cancer, Breast Diseases, +12 more
- Locations
-
- Wallace Tumor Institute- University of Alabama Birmingham, Alabama, United States
- Clearview Cancer Institute Huntsville, Alabama, United States
- University of Colorado Aurora, Colorado, United States
- Rocky Mountain Cancer Centers Lakewood, Colorado, United States
NCT01202591
- Conditions
- Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +5 more
- Locations
-
- Research Site Leuven, Belgium
- Research Site Namur, Belgium
- Research Site Brno, Czechia
- Research Site Prague, Czechia
Active, Not Recruiting
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
NCT04920708
- Conditions
- Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Addenbrookes Hospital Cambridge, Cambridgeshire, United Kingdom
- Royal Cornwall Hospital Truro, Cornwall, United Kingdom
- Mount Vernon Cancer Centre London, Surrey, United Kingdom
- Velindre Cancer Centre Cardiff, Wales, United Kingdom